Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 71

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 71
---
the offering prices of the securities we are offering and the exercise prices and other terms of the Warrants include the history and
prospects of our company, the stage of development of our business, our business plans for the future and the extent to which they have
been implemented, an assessment of our management, general conditions of the securities markets at the time of the offering and such other
factors as were deemed relevant.

<div align='center'>35</div>

Lock-up Agreements

We and each of our executive
officers, directors and holders of 5% or greater of our outstanding shares of common stock have agreed with the placement agent to be
subject to a lock-up period of 90 days following the date of closing of the offering pursuant to this prospectus.
This means that, during the applicable lock-up period, we and such persons may not offer for sale, contract to sell, sell, distribute,
grant any option, right or warrant to purchase, pledge, hypothecate or otherwise dispose of, directly or indirectly, any of our shares
of common stock or any securities convertible into, or exercisable or exchangeable for, shares of common stock, subject to customary exceptions.
The placement agent may waive the terms of these lock-up agreements in its sole discretion and without notice. In addition,
we have agreed to not issue any securities that are subject to a price reset based on the trading prices of our common stock or upon a
specified or contingent event in the future or enter into any agreement to issue securities at a future determined price for a period
of one year following the closing date of this offering, subject to an exception. The placement agent may waive this prohibition
in its sole discretion and without notice.

Indemnification

We have agreed to indemnify
the placement agent against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the placement
agent may be required to make with respect to any of these liabilities.

Regulation M

The placement agent may
be deemed to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act and any fees received by it and any profit
realized on the sale of the securities by it while acting as principal might be deemed to be underwriting discounts or commissions under
the Securities Act. The placement agent will be required to comply with the requirements of the Securities Act and the Exchange Act, including,
without limitation, Rule 10b-5 and Regulation M under the Exchange Act. These rules and